Which selective serotonin reuptake inhibitor (SSRI) is less likely to cause sexual dysfunction in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSRIs and Sexual Dysfunction in Men: Medication Selection

Bupropion is significantly less likely to cause sexual dysfunction in men compared to SSRIs and should be considered as a first-line alternative when sexual side effects are a concern. 1

Comparative Sexual Side Effect Profiles

SSRIs and Sexual Dysfunction

  • Sexual dysfunction is a common side effect of SSRIs, with significant differences in incidence among medications 1
  • Paroxetine has higher rates of sexual dysfunction than fluoxetine, fluvoxamine, nefazodone, or sertraline 1
  • According to FDA data, paroxetine is associated with ejaculatory disturbance rates of 13-28% and decreased libido in 6-15% of male patients 2
  • Sertraline causes ejaculation failure in approximately 14% of men and decreased libido in 6% of patients 3

Bupropion as a Superior Alternative

  • Bupropion has a significantly lower rate of sexual adverse events than fluoxetine or sertraline 1
  • In a double-blind comparison study, only 15% of men taking bupropion SR developed sexual dysfunction compared to 63% of men taking sertraline 4
  • Bupropion's mechanism as a dopamine-norepinephrine reuptake inhibitor likely contributes to its favorable sexual side effect profile 5, 6

Neurobiological Basis for Differences

  • Brain imaging studies show that paroxetine reduces activation in regions associated with sexual motivation (ventral striatum) and emotional/autonomic components of sexual arousal (anterior cingulate cortex) 5
  • Bupropion increases activation in regions including posterior midcingulate cortex, mediodorsal thalamus, and extended amygdala compared to paroxetine 5
  • These neurobiological differences likely explain the clinical observations of reduced sexual dysfunction with bupropion 5

Management Options

First-line Approach

  • For patients requiring antidepressant therapy where sexual dysfunction is a significant concern, bupropion should be considered as a first-line agent 1
  • Bupropion is as effective as SSRIs for treating depression while causing significantly fewer sexual side effects 6

For Patients Already on SSRIs

  • Adding bupropion to an existing SSRI regimen can effectively treat SSRI-induced sexual dysfunction in 66-75% of male patients 7, 8
  • Bupropion can be used either as a scheduled daily medication or on an as-needed basis 1-2 hours before sexual activity 7
  • Starting doses of 75-150mg of bupropion taken 1-2 hours before sexual activity can be effective, with potential increase to 75mg three times daily if needed 7

Important Caveats and Considerations

  • While bupropion has fewer sexual side effects, it may be associated with an increased risk for seizures compared to SSRIs 1
  • Venlafaxine may be associated with increased cardiovascular risks 1
  • Sexual dysfunction is likely underreported in clinical trials and may be more prevalent than documented 1
  • When switching medications, patients should be monitored for discontinuation symptoms and potential changes in depressive symptoms 1
  • For patients with comorbid anxiety disorders, SSRIs may still be preferred despite sexual side effects, as bupropion has less established efficacy for anxiety 1

Monitoring and Follow-up

  • Assess patient response and adverse effects within 1-2 weeks of initiating therapy 1
  • Physicians should routinely inquire about sexual side effects, as patients may be reluctant to report them spontaneously 3, 2
  • If inadequate response to initial therapy occurs within 6-8 weeks, consider medication adjustment 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.